Coherus Oncology, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $42.2 | $26.4 | $257.2 | $211.0 | $326.6 |
| Operating income | -$181.1 | -$199.7 | -$203.2 | -$256.9 | -$263.9 |
| Net income | $168.0 | $28.5 | -$237.9 | -$291.8 | -$287.1 |
| Cash Flow Statement | |||||
| Free cash flow | — | — | -$175.2 | -$243.2 | -$38.7 |
Shares outstanding 154.2M · Free float 83.8%
Annual filing data through FY ended December 31, 2025; float as of August 31, 2026.